199 related articles for article (PubMed ID: 16648340)
1. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study.
Murphy DG; Daly E; Schmitz N; Toal F; Murphy K; Curran S; Erlandsson K; Eersels J; Kerwin R; Ell P; Travis M
Am J Psychiatry; 2006 May; 163(5):934-6. PubMed ID: 16648340
[TBL] [Abstract][Full Text] [Related]
2. Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
Audenaert K; Van Laere K; Dumont F; Vervaet M; Goethals I; Slegers G; Mertens J; van Heeringen C; Dierckx RA
J Nucl Med; 2003 Feb; 44(2):163-9. PubMed ID: 12571204
[TBL] [Abstract][Full Text] [Related]
3. The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB.
Girgis RR; Slifstein M; Xu X; Frankle WG; Anagnostou E; Wasserman S; Pepa L; Kolevzon A; Abi-Dargham A; Laruelle M; Hollander E
Psychiatry Res; 2011 Dec; 194(3):230-234. PubMed ID: 22079057
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cortical 5-HT2A receptor binding in bulimia nervosa patients and healthy volunteers.
Goethals I; Vervaet M; Audenaert K; Van de Wiele C; Ham H; Vandecapelle M; Slegers G; Dierckx R; van Heeringen C
Am J Psychiatry; 2004 Oct; 161(10):1916-8. PubMed ID: 15465993
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: part 2--ketanserin displacement.
Catafau AM; Danus M; Bullich S; Nucci G; Llop J; Abanades S; Cunningham VJ; Eersels JL; Pavia J; Farre M
J Nucl Med; 2006 Jun; 47(6):929-37. PubMed ID: 16741301
[TBL] [Abstract][Full Text] [Related]
6. 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects.
Baeken C; D'haenen H; Flamen P; Mertens J; Terriere D; Chavatte K; Boumon R; Bossuyt A
Eur J Nucl Med; 1998 Dec; 25(12):1617-22. PubMed ID: 9871092
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.
Catafau AM; Danus M; Bullich S; Llop J; Perich J; Cunningham VJ; Plaza P; Penengo MM; Eersels JL; Squassante L; Ros D; Barbanoj M
J Nucl Med; 2006 Jun; 47(6):919-28. PubMed ID: 16741300
[TBL] [Abstract][Full Text] [Related]
8. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients.
Audenaert K; Van Laere K; Dumont F; Slegers G; Mertens J; van Heeringen C; Dierckx RA
Eur J Nucl Med; 2001 Feb; 28(2):175-82. PubMed ID: 11303887
[TBL] [Abstract][Full Text] [Related]
9. Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects.
Busatto GF; Pilowsky LS; Costa DC; Mertens J; Terriere D; Ell PJ; Mulligan R; Travis MJ; Leysen JE; Lui D; Gacinovic S; Waddington W; Lingford-Hughes A; Kerwin RW
Eur J Nucl Med; 1997 Feb; 24(2):119-24. PubMed ID: 9021107
[TBL] [Abstract][Full Text] [Related]
10. 5-HT2A receptors in the feline brain: 123I-5-I-R91150 kinetics and the influence of ketamine measured with micro-SPECT.
Waelbers T; Polis I; Vermeire S; Dobbeleir A; Eersels J; De Spiegeleer B; Audenaert K; Slegers G; Peremans K
J Nucl Med; 2013 Aug; 54(8):1428-33. PubMed ID: 23819924
[TBL] [Abstract][Full Text] [Related]
11. [Regional cerebral blood flow changes of right parietal lobe and superior temporal gyrus in Asperger's disorder in comparison with the patients with schizophrenia].
Seishin Shinkeigaku Zasshi; 2007; 109(1):50-4. PubMed ID: 17390711
[TBL] [Abstract][Full Text] [Related]
12. In vivo 5-HT2A receptor blockade by quetiapine: an R91150 single photon emission tomography study.
Jones HM; Travis MJ; Mulligan R; Bressan RA; Visvikis D; Gacinovic S; Ell PJ; Pilowsky LS
Psychopharmacology (Berl); 2001 Aug; 157(1):60-6. PubMed ID: 11512044
[TBL] [Abstract][Full Text] [Related]
13. Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders.
Haznedar MM; Buchsbaum MS; Hazlett EA; LiCalzi EM; Cartwright C; Hollander E
Am J Psychiatry; 2006 Jul; 163(7):1252-63. PubMed ID: 16816232
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the brain 5-HT2A receptor binding index in dogs with anxiety disorders, measured with 123I-5I-R91150 and SPECT.
Vermeire ST; Audenaert KR; Dobbeleir AA; De Meester RH; De Vos FJ; Peremans KY
J Nucl Med; 2009 Feb; 50(2):284-9. PubMed ID: 19164223
[TBL] [Abstract][Full Text] [Related]
15. Does DSM-IV Asperger's disorder exist?
Mayes SD; Calhoun SL; Crites DL
J Abnorm Child Psychol; 2001 Jun; 29(3):263-71. PubMed ID: 11411788
[TBL] [Abstract][Full Text] [Related]
16. Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D
Tsartsalis S; Tournier BB; Habiby S; Ben Hamadi M; Barca C; Ginovart N; Millet P
Neuroimage; 2018 Aug; 176():528-540. PubMed ID: 29723640
[TBL] [Abstract][Full Text] [Related]
17. Distinct patterns of grey matter abnormality in high-functioning autism and Asperger's syndrome.
McAlonan GM; Suckling J; Wong N; Cheung V; Lienenkaemper N; Cheung C; Chua SE
J Child Psychol Psychiatry; 2008 Dec; 49(12):1287-95. PubMed ID: 18673405
[TBL] [Abstract][Full Text] [Related]
18. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging.
Haznedar MM; Buchsbaum MS; Wei TC; Hof PR; Cartwright C; Bienstock CA; Hollander E
Am J Psychiatry; 2000 Dec; 157(12):1994-2001. PubMed ID: 11097966
[TBL] [Abstract][Full Text] [Related]
19. Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study.
Buchsbaum MS; Hollander E; Haznedar MM; Tang C; Spiegel-Cohen J; Wei TC; Solimando A; Buchsbaum BR; Robins D; Bienstock C; Cartwright C; Mosovich S
Int J Neuropsychopharmacol; 2001 Jun; 4(2):119-25. PubMed ID: 11466160
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors.
Abi-Dargham A; Zea-Ponce Y; Terriere D; al-Tikriti M; Baldwin RM; Hoffer P; Charney D; Leysen JE; Laruelle M; Mertens J; Innis RB
Eur J Pharmacol; 1997 Mar; 321(3):285-93. PubMed ID: 9085039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
